-
Product Insights
B.C 8.LF Field, Italy
B.C 8.LF upstream field is located in Zone B, Italy. The upstream field is owned by Edison Exploration & Production SpA (61.70%); Eni SpA (38.30%). It is operated by Edison Exploration & Production SpA. The project started its operations in 1982. B.C 8.LF Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end years,...
-
Product Insights
B.C 7.LF Field, Italy
B.C 7.LF upstream field is located in Zone B, Italy. The upstream field is owned by Edison Exploration & Production SpA (95%); Gas Plus Italiana SpA (5%). It is operated by Edison Exploration & Production SpA. The project started its operations in 1980. B.C 7.LF Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and...
-
Product Insights
B.C 2.LF Field, Italy
B.C 2.LF upstream field is located in Zone B, Italy. The upstream field is owned by Edison Exploration & Production SpA (95%); Gas Plus Italiana SpA (5%). It is operated by Edison Exploration & Production SpA. The project started its operations in 1980. B.C 2.LF Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and...
-
Product Insights
Cushman & Wakefield – LF Sakai Koga – Ibaraki
Equip yourself with the essential tools needed to make informed and profitable decisions with our Cushman & Wakefield - LF Sakai Koga - Ibaraki report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Cushman & Wakefield – LF Nara ANNEX – Nara
Equip yourself with the essential tools needed to make informed and profitable decisions with our Cushman & Wakefield - LF Nara ANNEX - Nara report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Cushman & Wakefield – LF Tsukuba New Construction Plan – Ibaraki
Equip yourself with the essential tools needed to make informed and profitable decisions with our Cushman & Wakefield - LF Tsukuba New Construction Plan - Ibaraki report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Cushman & Wakefield – LF Yatabe New Construction Plan – Ibaraki
Equip yourself with the essential tools needed to make informed and profitable decisions with our Cushman & Wakefield - LF Yatabe New Construction Plan - Ibaraki report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Parasitology and Mycology Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Parasitology & Mycology Rapid Tests & POC comprises of rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for Plasmodium and Candida albicans. The Parasitology and Mycology Rapid Tests and POC Â pipeline market research report provides comprehensive information about the Parasitology and Mycology Rapid Tests and POC Â pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Moreover, the report provides information...
-
Product Insights
Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Caspase-7 (CASP7) is a human protein encoded by the CASP7 gene. It is involved in the activation cascade of caspases responsible for apoptosis execution. It cleaves and activates sterol regulatory element binding proteins. The Caspase 7 - Drugs in Development research report provides a comprehensive overview on the therapeutics under development for CASP7, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological...
-
Sector Analysis
IT Management Market Size (by Technology, Geography, Sector, and Size Band), Trends, Drivers and Challenges, Vendor Landscape, Opportunities and Forecast, 2019-2025
The global IT management market has been quite resilient to the COVID-19-led disruptions in economic and business activities over the last two years. The total addressable market value for IT management solutions in terms of enterprise spending reached US$188.2 billion in 2020 and is now set to grow at a CAGR of more than 4% over the forecast period. This growth will be mainly led by continued demand for traditional IT management solutions such as operating systems, virtualization, and database...
-
Product Insights
Parasitology and Mycology Rapid Tests and POC – Medical Devices Pipeline Assessment, 2020
Parasitology & Mycology Rapid Tests & POC comprises of rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for the detection of pathogenic protozoans and fungi. GlobalData's Medical Devices sector report, “Parasitology & Mycology Rapid Tests & POC-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Parasitology & Mycology Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in...
-
Product Insights
Nuclear Imaging Equipment – Medical Devices Pipeline Assessment, 2018
Nuclear Imaging Equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. GlobalData's Medical Devices sector report, “Nuclear Imaging Equipment - Medical Devices Pipeline Assessment, 2018" provides comprehensive information about the Nuclear Imaging Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Nuclear Imaging Equipment Pipeline Assessment report provides key information and...
-
Product Insights
Cirrhosis Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Cirrhosis Global Clinical Trials Review, H1, 2019" provides an overview of Cirrhosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cirrhosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.